Eiji Shinozaki

Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency

Hideyuki Yanai, Kouki Nakamura, Susumu Hijioka et al. · The Journal of Biochemistry · 2010 · 94 citations

Immunology, Pathology, Delta-like 1 +20

Plasma <i>RAS</i> dynamics and anti-EGFR rechallenge efficacy in patients with <i>RAS/BRAF</i> wild-type metastatic colorectal cancer: REMARRY and PURSUIT trials.

Yoshinori Kagawa, Daisuke Kotani, Hideaki Bando et al. · Journal of Clinical Oncology · 2022 · 22 citations

Pursuit Trials, Immunology, Pathology +18

Real-world evidence of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer using an administrative claims database in Japan

Yoshinori Kagawa, Eiji Shinozaki, Ryota Okude et al. · ESMO Open · 2023 · 13 citations · Full text

A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer

Hiroki Osumi, Atsuo Takashima, Akira Ooki et al. · Translational Oncology · 2023 · 11 citations · Full text

Multicenter phase I/II trial of BBI608 and pembrolizumab combination in patients with metastatic colorectal cancer (SCOOP Study): EPOC1503.

Eiji Shinozaki, Akihito Kawazoe, Yasutoshi Kuboki et al. · Journal of Clinical Oncology · 2018 · 10 citations

Pembrolizumab Combination, Immunoediting, Immune Regulation +17